33 participants
Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-12-03
- Start Date:
- 2024-03-20
- Completion:
- 2028-01-15
Conditions
- Cutaneous Melanoma
- Brain Metastases
Interventions
- DRUG
No Results Yet